ENVERIC BIOSCIENCES, INC. Stock Redeemed or Called During Period, Value
ENVERIC BIOSCIENCES, INC. (ENVB) reported Stock Redeemed or Called During Period, Value of $527 for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-26.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2024-03-26
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for the quarter ending 2022-09-30 was $527.00.
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for the quarter ending 2016-09-30 was -$5.19M.
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for the quarter ending 2016-06-30 was $4.36M.
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for the quarter ending 2016-03-31 was $1.03M.
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for fiscal 2022 was $527.00.
- ENVERIC BIOSCIENCES, INC. stock redeemed or called during period, value for fiscal 2013 was -$100.00K.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 6 month | Stock Redeemed or Called During Period, Value 9 month | Stock Redeemed or Called During Period, Value 12 month |
|---|---|---|---|---|
| 2022-12-31 | $527.00 10-K · filed 2024-03-26 | |||
| 2022-09-30 | $527.00 10-Q · filed 2023-11-13 | |||
| 2016-09-30 | -$5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$832.60K derived: sum of 2 quarters · filed 2016-11-14 | $200.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $5.39M 10-Q · filed 2016-08-12 | ||
| 2016-03-31 | $1.03M 10-Q · filed 2016-05-16 | |||
| 2013-12-31 | -$100.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |